Multileaf Collimation Cardiac Shielding in Breast Radiotherapy: Cardiac Doses are Reduced, But at What Cost?
Authors:
- F.R. BartlettFBF.R. Bartlett
- J.R. YarnoldJYJ.R. Yarnold
- E.M. DonovanEDE.M. Donovan
- P.M. EvansPEP.M. Evans
- I. LockeILI. Locke
- A.M. KirbyAKA.M. Kirby
- 1 December 2013
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 25 (12) , 690-696
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast CancerNew England Journal of Medicine, 2013
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and SwedenRadiotherapy and Oncology, 2011
- Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977–2001Radiotherapy and Oncology, 2011
- Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutionsRadiotherapy and Oncology, 2010
- Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery – Audit on behalf of the IMPORT Trial Management GroupEuropean Journal of Surgical Oncology, 2009
- Cardiac Dose From Tangential Breast Cancer Radiotherapy in the Year 2006International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Cardiac Exposures in Breast Cancer Radiotherapy: 1950s–1990sInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registriesThe Lancet Oncology, 2005
- Reduction in Radiation Dose to Lung and Other Normal Tissues Using Helical Tomotherapy to Treat Lung Cancer, in Comparison to Conventional Field ArrangementsAmerican Journal of Clinical Oncology, 2003